GeoVax Labs, Inc. (GOVX) stock
GOVXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$2.02+0.31 (+18.48%)
Close on Nov 16, 2026Market cap $14.89MP/E –Yield –
GeoVax Labs total assets
Total assets on the balance sheet at the end of each period.
GeoVax Labs's total assets was $4.64M at Jun 30, 2026. For fiscal 2025 it was $6.34M, down 22.2% from the year before. Over ten years it grew 16.9% a year on average. The highest annual figure on record is $31.35M in fiscal 2022.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $6.34M | -22.2% |
| FY2024 | Dec 31, 2024 | $8.16M | -12.1% |
| FY2023 | Dec 31, 2023 | $9.28M | -70.4% |
| FY2022 | Dec 31, 2022 | $31.35M | +165.7% |
| FY2021 | Dec 31, 2021 | $11.80M | +13.5% |
| FY2020 | Dec 31, 2020 | $10.39M | +2116.8% |
| FY2019 | Dec 31, 2019 | $468.88K | -27.0% |
| FY2018 | Dec 31, 2018 | $642.06K | +31.0% |
| FY2017 | Dec 31, 2017 | $490.24K | -19.7% |
| FY2016 | Dec 31, 2016 | $610.22K | -54.2% |
| FY2015 | Dec 31, 2015 | $1.33M | -0.1% |
| FY2014 | Dec 31, 2014 | $1.33M | -53.0% |
| FY2013 | Dec 31, 2013 | $2.84M | +92.1% |
| FY2012 | Dec 31, 2012 | $1.48M | -10.2% |
| FY2011 | Dec 31, 2011 | $1.65M | -30.2% |
| FY2010 | Dec 31, 2010 | $2.36M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $4.64M | -13.2% |
| Q1 FY2026 | Mar 31, 2026 | $2.98M | -72.5% |
| Q4 FY2025 | Dec 31, 2025 | $6.34M | -22.2% |
| Q3 FY2025 | Sep 30, 2025 | $6.73M | -39.4% |
| Q2 FY2025 | Jun 30, 2025 | $5.35M | +30.7% |
| Q1 FY2025 | Mar 31, 2025 | $10.83M | +222.6% |
| Q4 FY2024 | Dec 31, 2024 | $8.16M | -12.1% |
| Q3 FY2024 | Sep 30, 2024 | $11.11M | -31.4% |
| Q2 FY2024 | Jun 30, 2024 | $4.10M | -80.7% |
| Q1 FY2024 | Mar 31, 2024 | $3.36M | -87.7% |
| Q4 FY2023 | Dec 31, 2023 | $9.28M | -70.4% |
| Q3 FY2023 | Sep 30, 2023 | $16.20M | -58.0% |
| Q2 FY2023 | Jun 30, 2023 | $21.25M | -36.1% |
| Q1 FY2023 | Mar 31, 2023 | $27.40M | +62.6% |
| Q4 FY2022 | Dec 31, 2022 | $31.35M | +165.7% |
| Q3 FY2022 | Sep 30, 2022 | $38.57M | +110.3% |
| Q2 FY2022 | Jun 30, 2022 | $33.24M | +67.7% |
| Q1 FY2022 | Mar 31, 2022 | $16.85M | -20.2% |
| Q4 FY2021 | Dec 31, 2021 | $11.80M | +13.5% |
| Q3 FY2021 | Sep 30, 2021 | $18.34M | +56.0% |
| Q2 FY2021 | Jun 30, 2021 | $19.82M | +1968.7% |
| Q1 FY2021 | Mar 31, 2021 | $21.12M | +2441.5% |
| Q4 FY2020 | Dec 31, 2020 | $10.39M | +2116.8% |
| Q3 FY2020 | Sep 30, 2020 | $11.76M | +1339.7% |
| Q2 FY2020 | Jun 30, 2020 | $957.94K | +179.6% |
| Q1 FY2020 | Mar 31, 2020 | $830.83K | +75.8% |
| Q4 FY2019 | Dec 31, 2019 | $468.88K | -27.0% |
| Q3 FY2019 | Sep 30, 2019 | $816.53K | +31.0% |
| Q2 FY2019 | Jun 30, 2019 | $342.63K | -7.7% |
| Q1 FY2019 | Mar 31, 2019 | $472.64K | -43.7% |
| Q4 FY2018 | Dec 31, 2018 | $642.06K | +31.0% |
| Q3 FY2018 | Sep 30, 2018 | $623.47K | +25.8% |
| Q2 FY2018 | Jun 30, 2018 | $371.38K | -62.5% |
| Q1 FY2018 | Mar 31, 2018 | $839.51K | +176.4% |
| Q4 FY2017 | Dec 31, 2017 | $490.24K | -19.7% |
| Q3 FY2017 | Sep 30, 2017 | $495.64K | -26.6% |
| Q2 FY2017 | Jun 30, 2017 | $990.01K | – |
| Q1 FY2017 | Mar 31, 2017 | $303.68K | – |
| Q4 FY2016 | Dec 31, 2016 | $610.22K | – |
| Q3 FY2016 | Sep 30, 2016 | $675.19K | – |
See a number that looks wrong?